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Dietary factors modulate gene expression and are able to alter epigenetic signatures in peripheral blood mononuclear cells
(PBMC). However, there are limited studies about the effects of omega-3 polyunsaturated fatty acids (n-3 PUFA) on the epigenetic
mechanisms that regulate gene expression. This research investigates the effects of n-3-rich fish oil supplementation on DNA
methylation profile of several genes whose expression has been reported to be downregulated by n-3 PUFA in PBMC:CD36, FFAR3,
CD14,PDK4, and FADS1. Young overweightwomenwere supplementedwith fish oil or control in a randomized 8-week intervention
trial following a balanced diet with 30% energy restriction. Fatty acid receptor CD36 decreased DNAmethylation at CpG +477 due
to energy restriction. Hypocaloric diet-induced weight loss also reduced the methylation percentages of CpG sites located in CD14,
PDK4, and FADS1. The methylation patterns of these genes were only slightly affected by the fish oil supplementation, being the
most relevant to the attenuation of the weight loss-induced decrease in CD36methylation after adjusting by baseline body weight.
These results suggest that the n-3 PUFA-induced changes in the expression of these genes in PBMC are not mediated by DNA
methylation, although other epigenetic mechanisms cannot be discarded.
1. Introduction
Several environmental factors, including dietary intake of
specific nutrients, germ-line genetic variations, stochastic
events, and inheritance systems, may change epigenetic
marks and affect gene expression [1, 2]. The most impor-
tant environmental factors associated with obesity onset are
sedentary lifestyles and unbalanced diets, such as the intake
of energy-dense foods [3]. The change of dietary habits and
physical activity patterns are the main strategy for managing
obesity and the associated disorders. Fatty fishes are rich in
long chain fatty acids, especially omega-3 polyunsaturated
fatty acids (n-3 PUFA), as exemplified by salmon and trout
[4]. Particularly, eicosapentaenoic acid (EPA; 20:5n-3) and
docosahexaenoic acid (DHA; 22:6n-3) are the n-3 PUFA
occurring in fish oil that have been more comprehensively
studied due to their health improving effects [5]. For instance,
the consumption of an overall healthy diet including fatty fish
at least twice a week is a recommendation for reducing the
risk of developing cardiovascular diseases [6]. Furthermore,
n-3 PUFA have also been proposed to reduce proinflam-
matory cytokine production and decrease obesity-induced
insulin resistance [7]. Although epidemiological associations
between n-3 PUFA intake and obesity are inconclusive, some
cross-sectional studies have demonstrated inverse relation-
ships between them [8].
Consumption of n-3 PUFA affects the expression ofmany
genes in various cell types and tissues, including liver [9],
adipose tissue [10], and bloodwhite cells [11, 12]. In peripheral
blood mononuclear cells (PBMC), n-3 PUFA supplementa-
tion has been reported to downregulate the expression of
genes related to fatty acid transport, such as fatty acid desat-
urase 1 (FADS1) and fatty acid receptor 3 (FFAR3), in insulin
resistant subjects [11] as well as other genes such as CD36
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Figure 1: Flow chart of the participants in the study.
molecule (CD36), the cluster of differentiation 14 (CD14), and
pyruvate dehydrogenase kinase 4 (PDK4) in healthy elderly
subjects [12]. However, few studies have examined the effects
of PUFA supplementation on DNA methylation, a key epi-
genetic mechanism for gene expression regulation. In vitro,
EPA treatment reduced the demethylation of one CpG at the
promoter of CCAAT/enhancer-binding protein 𝛿 (C/EBP𝛿)
in U937 leukemia cells [13]. In rodents, n-3 PUFA sup-
plementation during pregnancy and/or lactation increased
liver FADS2 DNA methylation in the offspring [14]. FADS2
methylation was increased in the liver of dams exposed to
an n-3 PUFA-deficient diet during pregnancy followed by
postnatal supplementation diet containing n-3 PUFA from
flaxseed oil [15]. On the other hand, n-3 PUFA supplemen-
tation during pregnancy increased global DNA methylation
levels in rats supplemented with folic acid in the absence of
vitamin B12 [16]. However, other authors analyzed themethy-
lation pattern of genes in mouse epididymal fat (leptin, leptin
receptor, and proopiomelanocortin) and did not find effects
as a result of fish oil supplementation [17]. Up to date, there is
no report about the effects of n-3 PUFA supplementation on
DNA methylation in adult humans.
Hence, the aimof the present studywas to test the hypoth-
esis whether fish oil supplementation within an energy-
restricted dietary treatment affects the DNA methylation
pattern of genes that are downregulated by n-3 PUFA sup-
plementation in PBMC, such as the fatty acid receptorsCD36
and FFAR3, the enzymes FADS1 and PDK4, and the surface
antigen CD14.
2. Methods
2.1. Trial Design and Participants. The primary study was
based on a randomized 8-week intervention trial study of four
isocaloric diets, designed to investigate the specific effects of
fish consumption or fish oil supplementation on weight loss
in young overweight adults (trial registration: ClinicalTri-
als.gov NCT00315770) [18]. In this clinical trial, a total of 324
overweight individuals were included (140 from Iceland, 120
from Spain, and 64 from Ireland) and randomly assigned to
four diets groups (control, cod, salmon, and fish oil capsules)
[18]. Detailed description of the protocol, participant recruit-
ment and enrolment, and inclusion and exclusion criteria
are described elsewhere [18, 19]. Briefly, the initial inclusion
criteria were body mass index (BMI) 27.5–32.5 kg/m2, age
between 20 and 40 years old, andwaist circumference≥94 cm
and ≥80 cm for men and women, respectively. Exclusion
criteria were weight change due to weight-loss diet within 3
months before the start of the study, use of supplements
containing n-3 fatty acids, calcium, or vitamin-D during the
last 3months, drug treatments of diabetesmellitus, hyperten-
sion, or hyperlipidemia, and women’s pregnancy or lactation.
As the objective of the paper is to examine the effects of
fish oil supplementation on the DNA methylation pattern of
genes that are downregulated by n-3 PUFA supplementation
in PBMC, we only analyzed Spanish subjects from two of the
intervention groups: control and fish oil (Figure 1). A selec-
tion of the individuals of these two groups was performed,
taking into account their age, biochemical, and anthropomet-
ric characteristics. The reasons for this selection were that (i)
it was necessary to match the individuals according to their
age, life style, biochemical, and anthropometric charac-
teristics in order to diminish heterogeneity and to avoid
confounding environmental factors and (ii) the high cost of
the epigenetic determinations implied that they could not be
applied to a large number of patients. In a first moment, two
more subjects from each group had been selected but, unfor-
tunately, the quality of their DNA samples was under the
quality standards of the procedure and could not be included
in the analysis. Because we aimed to evaluate DNA methy-
lation changes in response to fish oil supplementation, we
selected participantswith PBMC samples available at baseline
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and endpoint. Furthermore, due to the low number of men
in the intervention groups, men were excluded. So, the
DNA methylation study was conducted in 12 young over-
weight/obese women of similar characteristics that belonged
to the two following groups: control (𝑛 = 5) and fish oil (𝑛 =
7). To reduce variability, subjects belonging to the cod and
salmon groups were not analyzed because if changes in
DNA methylation were observed in these groups, it would
be impossible to find the responsible agents due to the big
differences in macronutrients and micronutrients between
both fish species.The studywas approved by the Ethical Com-
mittee of the University of Navarra and followed the Helsinki
guidelines. All participants gave their written consent after
being informed of the nature purpose and possible risks of the
study. This study was performed at the University of Navarra
in Pamplona, Spain, and recruitment was undertaken during
2004 and 2005.
2.2. Dietary Intervention. Overweight young women were
instructed to follow a diet with 30 percent fewer calories than
the estimated energy expenditure (approximately 600 kcal/
day), for eight consecutive weeks. As described earlier [18],
basal metabolic rate was estimated by applying Harris-Bene-
dict equations and a correction factor due to the overweight
status of the subjects [20, 21]. To estimate total energy expen-
diture, the physical activity level was set to 1.3, as a relatively
low physical activity level was reported by all subjects [18].
PAL was estimated according to the Nordic Nutrition Rec-
ommendations, 2004 [22].The questionnaire asked about the
occupation, sleeping hours, and additional activities at work
and during the rest of the day.The physical activity question-
naire included representative values expressed as multiples
of Resting Energy Expenditure (REE). Average daily exercise
was calculated taking into account the intensity level and time
spent on each activity. Finally, activities were quantified with
respect to the Resting Energy Expenditure (1.0). The subjects
under weight loss treatment were randomly single-blindedly
assigned to control group (6 placebo capsules/day) or fish
oil group (6 capsules/day). Both capsules were from Loders
Croklaan (Lipid Nutrition), Wormerveer, the Netherlands,
encapsulated by Banner Pharmacaps, Tilburg, the Nether-
lands. Participants from both control and fish oil groups were
instructed not to eat seafood because it could complicate the
analysis that would be translated into unknown variability.
So, seafood was simply stopped for the intervention period.
Each subject received a detailed meal plan to follow, as
well as recipe booklets and instructions, so as to minimize
differences between diets in terms of sources of fat, fruit
and vegetable consumption, and meal frequency. Diets were
similar in total fat (30%of total energy), carbohydrate (50%of
total energy), protein (20% of total energy), and dietary fiber
(20–25 g) [18, 19]. Amounts of long chain n-3 fatty acid intake
were <260mg/day for the control and >1300mg/day for the
fish oil groups, as elsewhere described [23].
2.3. Anthropometric and Metabolic Measurements. Anthro-
pometric parameters measurements and blood samples col-
lections were carried out at baseline and after supple-
mentation period (endpoint), as previously described [24].
Plasma levels of glucose, total cholesterol, and triacylglycerols
were measured by specific colorimetric assays (Horiba ABX
Diagnostics, Montpellier, France) using an automatic system
(COBASMIRA, Roche, Basel, Switzerland), whereas circulat-
ing insulin levels were determined by ELISA (Mercodia, AB,
Uppsala, Sweden). The homeostasis model assessment index
(HOMA-IR) was calculated according to Matthews et al. [25]
in order to assess insulin resistance.
2.4. PBMC Isolation, DNA Extraction, and Bisulfite Con-
version. PBMC were isolated by differential centrifugation
using Polymorphprep (Axis Shield PoC AS, Oslo, Norway),
as previously described [26], and stored at −80∘C. DNA
was extracted using AllPrep DNA/RNA Mini Kit (Qiagen,
Hilden, Germany). DNA concentration was quantified with
Quant-iT PicoGreen dsDNAAssay Kit (Invitrogen, Carlsbad,
CA, USA) and genomic DNA (2 𝜇g) was bisulfite-converted
with the EpiTect Bisulfite Kit (Qiagen, Valencia, CA, USA).
2.5. Methylation Profile Determined by MALDI-TOF Mass
Spectrometry. The DNA methylation profiles of five genes
were analyzed in PBMC: CD36, CD14, FADS1, PDK4, and
FFAR3. The genomic sequences studied are shown in Table
1S in supplementarymaterials available online at http://dx.doi
.org/10.1155/2014/675021.
Firstly, a region covering 3 kb (2,000 base pairs upstream
to 1,000 base pairs downstream from the transcriptional start
site) was chosen from Gene Bank (http://www.ncbi.nlm.nih
.nih.gov/gene) for each gene. CpG islands were identified
using MethPrimer software (http://www.urogene.org/meth-
primer/) [27]. Whereas three genes showed CpG islands
(CD14, PDK4, and FADS1), neither FFAR3 nor CD36 showed
these CpG dinucleotide-rich regions. Predicted transcription
factor binding sites were identified with AliBaba2 software
(http://www.gene-regulation.com/pub/programs/alibaba2/
index.html) with a homology of 75%.Then, a region of 300 to
500 bp in a CpG island and/or rich in predicted transcription
factors was chosen for each gene (Table 1). The methylation
profile of these genes was determined by Sequenom’s
MassARRAY EpiTyper technology (Sequenom, San Diego,
CA, USA), which relies on base-specific cleavage followed
by MALDI-TOF mass spectrometry as previously described
[28]. The primers used are reported in Table 1. DNA meth-
ylation values of some CpG sites could not be measured
independently. This is the case of nearby CpG sites and
CpG sites included in similar chemical fragments after the
enzymatic breakdown. So, they were clustered together and
were considered as an independent CpG site when analyzed.
2.6. Statistical Analysis. Thedata are presented as the mean ±
SD and were analyzed using SPSS 15.0 for Windows (SPSS,
Chicago, IL, USA). A general linear model with repeated
measures was conducted to assess the impact of oral sup-
plementation (control or fish oil) on DNA methylation of
CD36, FFAR3, CD14, PDK4, and FADS1 through the weight
loss treatment (baseline and endpoint). For CpG site +477
from CD36 gene, we hypothesized that the differences in
initial body weight may affect statistical analysis. In order
to control the effect of the body weight, statistical analyses
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Table 1: Primers used for the bisulfite conversion of DNA.
Symbol Primers Product size CpG in regiona
CD36 L: GGGTTGAGAGTTTGTGTTTTATTTTTR: TTCAAATACAATTACACTTTTTAAAATCAC 479 4
FFAR3 L: GGTAAATTGGATAAATGTTATTTTAGAGAR: CAACAAAAAAACACCAAAATACTCC 385 9 (7)
CD14 L: GGAGGGAATTGAATGATATTTTAGGR: AAATCTCCACCTCTACTACAAACACA 429 24 (20)
PDK4 L: TTTTGTTTTGAGTAAGGATTAATGAR: TCCCAAACAAAAAAAATCACTAAAA 400 23
FADS1 L: TTGTAATTTTTAAGGGTTTTTAGGTR: AAACAACTCACAACTAAACTACCAACA 419 37 (35)
aValues between parenthesis indicate the number of CpGs covered by Sequenom EpiTyper approach. L: left primer; R: right primer; Chr: chromosome; CD36:
thrombospondin receptor; CD14: cluster of differentiation 14; FADS1: fatty acid desaturase 1; PDK4: pyruvate dehydrogenase kinase, isozyme 4; FFAR3: free
fatty acid receptor 3.
Table 2: Anthropometric and serum variables from control and fish oil supplemented women before and after the 8-week weight loss
treatment.
Control Fish oil Interaction Weight loss treatment Oral suppl.
Baseline Endpoint Baseline Endpoint
Anthropometric
Age, years 35.1 ± 5.5 — 32.4 ± 5.0 —
Height, m 1.65 ± 0.06 — 1.61 ± 0.05 —
Weight, kg 82.9 ± 2.3 78.7 ± 3.0 78.8 ± 5.2 73.6 ± 5.6 ns. 𝑃 < 0.05 ns.
BMI, kg/m2 30.7 ± 2.0 29.1 ± 2.6 30.5 ± 1.7 28.4 ± 1.8 ns. 𝑃 < 0.05 ns.
SBP, mmHg 120.6 ± 9.6 121.8 ± 8.3 115.4 ± 9.5 113.1 ± 5.7 ns. ns. ns.
DBP, mmHg 67.2 ± 4.1 68.4 ± 2.9 72.1 ± 6.5 68.9 ± 5.6 ns. ns. ns.
Serum
Glucose, mg/dL 86.9 ± 4.6 85.1 ± 3.2 88.1 ± 6.0 90.6 ± 9.7 ns. ns. ns.
Insulin, mU/L 8.4 ± 4.0 8.2 ± 4.0 12.4 ± 6.7 8.3 ± 3.3 ns. ns. ns.
HOMA index 1.8 ± 0.9 1.7 ± 0.7 2.7 ± 1.5 1.8 ± 0.7 ns. ns. ns.
Leptin, 𝜇g/mL 37.6 ± 10.7 25.4 ± 8.4 30.6 ± 14.5 18.5 ± 8.0 ns. 𝑃 < 0.05 ns.
Total cholesterol, mg/dL 214.9 ± 49.0 200.1 ± 44.9 197.4 ± 46.5 185.4 ± 35.1 ns. ns. ns.
LDL cholesterol, mg/dL 132.5 ± 30.9 124.8 ± 26.9 114.0 ± 40.6 114.5 ± 29.7 ns. ns. ns.
HDL cholesterol, mg/dL 65.2 ± 21.2 58.2 ± 24.7 57.0 ± 11.0 52.7 ± 8.8 ns. ns. ns.
Triglycerides, mg/dL 85.9 ± 48.7 85.8 ± 26.1 131.9 ± 75.0 88.1 ± 35.3 ns. ns. ns.
Data represent mean ± SD (control 𝑛 = 5; fish oil group 𝑛 = 7). Differences within and between subjects were determined by a general linear model with
repeated measures. ns.: not significant; SBP: systolic blood pressure; DBP: diastolic blood pressure; HOMA: homeostasis model assessment; Oral suppl.: effect
of the oral supplementation of fish oil.
were conducted with baseline body weight as a covariable.
The significance level was set at 𝑃 < 0.05.
3. Results
3.1. Baseline DNA Methylation Profile. Recruitment was
undertaken during 2004 and 2005. A total of 12 women
were selected for the present study (Figure 1). Different
patterns of methylation were found in the genes studied in
PBMC (Figure 2). Low methylation levels (less than 25%
[29]) were observed in the genes that encode the superficial
moleculeCD14 and themetabolic enzymes PDK4 and FADS1,
although one CpG of PDK4 (−229−227) was highly methy-
lated (more than 75% [29]). CD36 studied region was highly
methylated, whereas FFAR3 showed two distinct regions: a
highly methylated region close to the transcription start site
(CpG sites −18, +33, and +77) and a low-methylated region
between CpGs −53 and −202.
3.2. Weight Loss Treatment and Fish Oil Supplementa-
tion Effects on DNA Methylation Profile. Both experimental
groups (control and fish oil) responded similarly to theweight
loss treatment (Table 2), showing similar reductions in body
weight, BMI, and serum leptin levels (𝑃 < 0.05) but no effects
on other metabolic parameters.
Hypocaloric diet-induced weight loss affected DNA
methylation in the CD36 gene, reducing the percentage of
methylation of CpG +477 (Figure 3(a)). This CpG lies in
BioMed Research International 5
CREP
CPE bind
CRE-BP1
CRE-BP
ACE2100
80
60
40
20
0
M
et
hy
la
tio
n 
(%
)
+95 +167 +477 +498
(a)
CREB-2
CREB
REV-ErbA
ATF
C/EBP𝛼 Sp1
Sp1
Sp1
Sp1
YY1
−
14
6
−
9
6
−
5
3
−
4
2
−
18
+
3
3
+
7
7
100
80
60
40
20
0
M
et
hy
la
tio
n 
(%
)
CRE-BP1
ATF
AP-2𝛼
−
20
2
−
19
9
##
(b)
+
5
16
+
5
4
7
+
5
5
0
+
5
5
7
+
5
9
8
+
6
13
+
6
54
+
6
25
+
6
6
9
+
7
24
+
7
26
+
7
28
+
7
5
5
+
7
6
5
+
7
7
3
+
7
7
9
+
80
1
+
81
4
+
81
9
+
83
4
+
84
6
+
85
5
+
65
8
+
66
0
100
80
60
40
20
0M
et
hy
la
tio
n 
(%
)
# # # Sp1Sp1
Sp1
Adf-1 GAL4
AP-2
USF
Sp1
GABP
NF-𝜅B
C/EBP𝛼
(c)
100
80
60
40
20
0M
et
hy
la
tio
n 
(%
)
3
3
3
−
−
3
3
1
−
27
1
−
25
4
−
24
4
22
9
−
−
22
7
−
22
2
−
21
4
−
18
6
−
13
1
12
2
−
−
12
0
−
11
3
−
9
7
−
88
−
6
4
−
6
2
−
5
0
−
17
−
15
+
3
+
5
Sp1 Sp1 Sp1
Sp1
Sp1 Sp1 Sp1
c-Myc
CRE-BP1 
CREB 
Sp1
ER
YY1
AP-1
CP1
CPE bind
CPE bind
CREB 
AP-2𝛼
C/EBP𝛼
C/EBP𝛼
#
(d)
−
3
10
−
29
4
−
28
9
−
28
6
−
24
6
−
23
3
−
20
0
−
19
8
−
19
4
−
19
0
−
18
0
−
17
4
15
7
−
−
15
1
−
13
6
−
12
7
−
9
1
−
89
−
83
−
5
9
−
4
7
−
4
5
−
4
2
−
25
−
22
−
20
−
13 −
6
+
6
+
12
+
15
+
18
+
21
+
3
6
+
3
8
+
4
6
+
4
8
100
80
60
40
20
0M
et
hy
la
tio
n 
(%
)
##
CPE bind
Sp1; c-Jun
c-Fos; CREB
C/EBP𝛼
CRE-BP1
RXB-𝛽
E1A 12Sc/EBP𝛼
USF
Sp1
Ap-2𝛼
Egr-1Represso
Sp1
ENKTF1
AP-2𝛼
AP-2𝛼
YY1
NF1
GR
Ap1
Sp1
Sp1
Sp1
Sp1 Sp1 Sp1 Sp1
Sp1
Sp1
Sp1
Krox-20
Sp1
represso
NF𝜇E1
(e)
Figure 2: Baseline DNA methylation profile of the genes (a) CD36, (b) FFAR3, (c) CD14, (d) PDK4, and (e) FADS1 as determined in PBMC
from overweight young women before weight loss treatment.The bars represent methylation levels of each CpG and are numbered according
to the transcription start site. The predicted binding sites for transcription factors that are associated with the CpGs (identified by AliBaba
software with a homology of 75%) are also indicated. Data are mean ± SD, 𝑛 = 12. #Not analyzed.
a putative binding site for the transcription factors CREB
and CRE-BP1 (Figure 2(a), CpG +477). However, fish oil
supplementation did not alter the DNA methylation pattern
of CD36 gene, with reductions of 11.8% in the methylation of
CpG +477 in the control group and 7.3% in the fish oil group.
In order to control the effect of body weight, methylation
status was adjusted to baseline body weight. In this case, the
methylation of CpG +477 was lower (𝑃 < 0.05) in the fish oil
group (6.7%) than in the control group (12.7%).
Energy restriction also affected DNA methylation in
CD14 (Figure 3(c)) but only with a very slight increase of
0.3% and 0.6% at the CpGs +765+773 in the control and the
fish oil groups, respectively. These CpGs are included in a
putative binding site for the transcription factors USF and Sp1
(Figure 2(c)).
Statistically significant (although small) changes were
also induced by the hypocaloric diet-induced weight loss in
the promoters of PDK4 and FADS1 genes (CpGs −254 and
−25−22−20, resp., in Figures 3(d) and 3(e)). Furthermore, the
only CpGs that showed significant methylation differences
between the control and the fish oil groups are in these
genes. Thus, the methylation percentage of PDK4 CpG sites
−222 and −50 and FADS1 CpG −25−22−20 were reduced in
the control group and increased with fish oil, whereas the
reduction observed in PDK4 CpG −254 in the controls was
greater than in the fish oil group. Interestingly, PDK4 CpGs
−254 and −50 lay in putative binding sites for the transcrip-
tion factor Sp1 (Figure 2(d)). Nevertheless, although statis-
tically significant, these differences were so small that they
probably do not influence gene expression.
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Figure 3: Methylation of the CpGs located in the studied regions of the genes (a) CD36, (b) FFAR3, (c) CD14, (d) PDK4, and (e) FADS1 in
PBMC from control and fish oil-supplemented women during the 8-week weight loss treatment. Data represent mean ± SD (control 𝑛 = 5;
fish oil 𝑛 = 7). DNA methylation was determined at baseline and endpoint samples by MassARRAY EpiTyper in triplicate. A general linear
model with repeated measures was used to assess the impact of oral supplementation on DNA methylation (between subjects) across the
weight loss treatment (within subjects). ∗𝑃 < 0.05, differences due to weight loss (baseline versus endpoint); #𝑃 < 0.05, interaction between
weight loss effect and oral supplementation.
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4. Discussion
Although there is strong evidence of themodulatory effects of
n-3 PUFA on gene expression in several cell types in humans,
it is not known if they could act on gene expression by altering
the epigenetic mechanism of DNA methylation. Herein,
we sought to determine the methylation profiles of CD36,
FFAR3, CD14, PDK4, and FADS1 in PBMC and whether this
methylation is affected by a weight loss nutritional interven-
tion (energy-restriction) with or without fish oil supplemen-
tation in young overweight women. As expected, phenotypic
changes due to energy restriction led to a reduction in
bodyweight. In humans, energy-restricted dietsmodifyDNA
methylation in PBMC [28]. Our results corroborate these
findings, suggesting that weight loss treatment induces small
changes in the methylation profile of specific genes from
blood cells (i.e., CD36, CD14, PDK4, and FADS1).
CD14, PDK4, and FADS1 have low methylation percent-
ages (<25%) in PBMCbefore starting nutritional intervention
(Figure 2). Similar results have been reported for PDK4
(<10%) in human skeletal muscle [30] and for CD14 and
FADS1 in PBMC [31] and murine aorta [32], respectively.
On the other hand, CD36 and FFAR3 have been found to
be highly methylated in PBMC. Whereas the methylation of
CD36 has not been previously described, a hypomethylated
region close to FFAR3 has been reported in the adult
hematopoietic compartment [33].
The five genes studied have been reported to be downreg-
ulated in PBMC from fish oil-supplemented subjects [11, 12].
Although few studies (all of them in animal models) have
analyzed the effect of fish oil on DNA methylation, it has
been observed that the epigenetic effects of n-3 PUFA depend
on the gene and the tissue and are far more relevant during
pregnancy and lactation than during adult life [14–17]. In the
current study, very small methylation differences have been
found between the control and the fish oil groups. Impor-
tantly, fish oil supplementation did not potentiate the 8-week
hypocaloric diet-induced weight loss in our study. Although
it has been described that fish oil supplementation could
improveweight loss inmenwith caloric restriction [18], other
studies have not found an improvement of weight loss in
postmenopausal women with type 2 diabetes [34] or hyper-
insulinemia [35]. This finding is important for approaching
the discussion of the methylation results because the changes
observed in the n-3 PUFA-supplemented group cannot be
attributed to shifts in anthropometric or biochemical param-
eters with the intervention.
The most relevant effect due to n-3 PUFA supplemen-
tation was found in CD36 CpG +477 (after adjusting for
baseline body weight). CD36 encodes a membrane glyco-
protein that belongs to the class B scavenger receptor family
that may play an important role in lipid metabolism in
humans and may be involved in obesity-related complica-
tions [36]. In macrophages, it is responsible for binding
and internalization of oxidized LDL while in metabolically
active tissues, especially in adipocytes, heart and skeletal
muscle, CD36 mediates the uptake of long-chain fatty acids
across the plasma membrane [36]. In macrophages and
monocytes, CD36 promotes lipid uptake leading to activation
of PPAR𝛾 transcriptional pathways and may also promote
inflammatory response and phagocytosis [37]. Thus, THP-
1 macrophages treated with oleic acid, linoleic acid, EPA,
and DHA showed increased CD36 mRNA expression [38].
Similarly, the expression of CD36 was increased in PBMC
after oral acute intake of MUFA-rich virgin olive oil [39] and
in monocytes after 24 h lipid infusion [40] in humans. On
the other hand, the expression ofCD36was downregulated in
PBMC due to a long-term supplementation with EPA/DHA
[12]. These results indicate that the type of fatty acids (PUFA
or MUFA) regulates CD36 expression in a different manner
depending also on the time (acute versus chronic). In our
8-week long study, the hypocaloric diet-induced weight loss
decreased CD36 gene DNA methylation (in CpG +477) with
less intensity in the fish oil-supplemented group than in the
controls. However, the small decrease observed does not,
probably, influence the regulation of CD36 gene expression.
An epigenetic change may influence CD36 gene expres-
sion in blood cells and may contribute to modify inflam-
matory monocyte/macrophage activation during weight loss
treatment. This notion is supported by the fact that PBMC
from obese women have a proinflammatory state, with
increased expression in PBMC of proinflammatory genes
like tumor necrosis factor-𝛼 (TNF-𝛼), interleukin-6 (IL-6),
migration inhibitor factor (MIF), and matrix metallopro-
teinase-9 (MMP9) and an increase in NF-𝜅B binding to DNA
[41]. CD36 CpG +477 lies in a recognition motif for CRE-
BP1 and CREB, members of the leucine zipper family of
DNA binding proteins that bind to cAMP-response elements
(CRE) [42]. Both transcription factors (CREB and CRE-
BP1) also interact with CREB binding protein (CBP)/p300
associating factor, which, as CRE-BP1, is a knownHATor his-
tone acetyltransferase [43, 44] and may promote chromatin
modifications by inducing histone acetylation. If transcrip-
tion factor-DNA binding affinity is affected by cytosine
methylation, the HAT activity might be downregulated and
histone deacetylation increased, which could justify the
underexpression of the target genes, as described in PBMC
from subjects supplemented with fish oil [12]. Besides the
small number of participants included in the present study,
we found a clear effect of weight loss treatment on the
methylation percentage of many CpG sites, especially in the
promoter region ofCD36. Our translational research demon-
strates that dietary energy-restriction results in epigenetic
adaptations in PBMC cells. However, as only 12 subjects were
analyzed, the results could not be extrapolated to the whole
population and should be validated in larger and more com-
plex populations. In any case, the results are of very high value
because the individuals have been carefully selected from a
big population and matched trying to minimize other con-
founding factors apart from the dietary intervention (fish oil
capsules or not).
The small differences (<2%) observed in DNA methy-
lation between the control and the fish oil groups in CpGs
located in PDK4 and FADS1, although statistically significant,
probably do not affect the expression of the genes. Both
genes have been previously reported to be regulated by DNA
methylation: physical exercise immediately decreased PDK4
methylation in skeletal muscle [45], whereas subjects with
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type 2 diabetes presented higher PDK4 expression in skeletal
muscle accompanied by a tendency to reduce promoter DNA
methylation when compared with normal glucose tolerance
subjects [30]. On the other hand, FADS1 expression was
regulated by DNA methylation in a gastric cancer cell line
as demonstrated by treating the cells with the demethylating
agent 5-aza-2󸀠-deoxycytidine, which increased by 23-fold
FADS1 mRNA expression [46]. A recent study did not find
modifications in FADS1 methylation in offspring aorta as a
result of changes in the lipid composition of the maternal
diet [32]. Considering the transcription factors associated
with the CpG sites affected, Sp1 is an ubiquitously expressed
transcription factor that participates in the overexpression
of CD14 during monocytic cell differentiation by interacting
with another protein, MEF2D [47]. However, the small
methylation changes observed in this study probably do not
affect the binding properties of Sp1 in the studied genes.
In summary, an 8-week weight-loss nutrition interven-
tion not only reduced body weight and circulating leptin in
overweight women but also modified DNA methylation of
CD36 in PBMCand, very slightly, ofCD14,PDK4, and FADS1.
Although fish oil oral supplementation did not potentiate the
weight-loss effects of the hypocaloric diet, it modulated DNA
methylation, that is, reducing the decrease in DNA methy-
lation of CD36 CpG +477 (after adjusting by baseline body
weight).These results should be interpretedwith care because
the methylation differences are rather small and restricted to
few CpG sites, but it should be highlighted that other nutri-
tional studies, including several ones focused on body weight
loss [29, 48, 49], have found DNA methylation changes of
similar magnitude.
In any case, to be sure that the beneficial effects of EPA/
DHA in obesity, type 2 diabetes, and other metabolic diseases
are mediated by changes in the DNA methylation pattern, in
addition to PBMC, other tissues (such as adipose depots, liver,
or skeletal muscle) should be analyzed. Finally, the changes
in DNA methylation should be compared with those in the
expression of the corresponding genes in these tissues.
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